With an expiration date still more than a year away, here's what the latest details reveal.

Women are driving soaring use of ADHD medication, experts say. Researchers from the University of Oxford highlighted a 20-fold rise in use of drugs to manage the condition among w ...

FDA fast tracks ADHD drug centanafadine, targeting approval by July 24 for treatment across all age groups, based on phase 3 trial results.

Some adult professionals living with attention-deficit hyperactivity disorder (ADHD) manage their work tasks without much disruption. But others may face challenges like losing focus, struggling to ...

Shorter wait times and lower costs. That’s what people with ADHD and their families can expect now Victorian GPs are getting ...

The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.

From 2022 to 2024, stimulant prescriptions issued in Connecticut increased by 13.2 percent, according to data from the state.

Please provide your email address to receive an email when new articles are posted on . Asian, Black and Hispanic children with ADHD were less likely to be prescribed medication early vs. white ...

Finding the right ADHD prescription can feel overwhelming at first. With dozens of stimulant and nonstimulant ADHD medications available, many people search for clarity on how these medications work, ...

Changes proposed by the Allan government will seek to cut down a process that can take up to a year and costs at least $2000.

Some clinicians are concerned by these results, while some people say a diagnosis brought validation and life-changing help.